Synergetics USA Earnings: Everything You Must Know Now

  Google+ | + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Synergetics USA, Inc. (NASDAQ:SURG) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.

Synergetics USA, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 25% to $0.06 in the quarter versus EPS of $0.08 in the year-earlier quarter.

Revenue: Rose 5.93% to $17.86 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Synergetics USA, Inc. reported adjusted EPS income of $0.06 per share. By that measure, the company met the mean analyst estimate of $0.06. It beat the average revenue estimate of $17.01 million.

Quoting Management: “We were pleased with our fourth quarter revenue performance, particularly in the U.S., where we saw improving trends in our ophthalmic sales of both new and base business products. Commercialization of the VersaVIT™ system remains on-track as we continue to establish a solid installed base. Fourth quarter results also benefitted from strong demand from our OEM partners,” said David M. Hable, the Company’s President and Chief Executive Officer. “Our international results were softer than anticipated, driven by ongoing weakness in our base business and lower contributions from emerging markets compared to last year. The recent acquisition of our U.K. distribution partner, M.I.S.S. Ophthalmics, contributed modestly to international revenues in the period, and we look forward to incremental contributions in fiscal 2014.”

Key Stats (on next page)…

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business